The Motley Fool··Prosper Junior BakinyRegeneron's Pipeline Depth and Dupixent Dominance Set Stage for Decade of Growth
Regeneron's Dupixent dominance and deep pipeline across weight management, oncology, and rare diseases position the company for sustained growth through the mid-2030s.
REGNbiotechpatent cliff